Argenx Se (ARGX) Assets Average (2016)

Argenx Se's (ARGX) quarterly Assets Average came in at $82.3 million in Q4 2016.

Argenx Se (ARGX) Assets Average (2016) Analysis & Trends

Argenx Se (ARGX) has 1 years of Assets Average data on file, last reported at $82.3 million in Q4 2016.

Quarterly Assets Average changed N/A year-over-year to $82.3 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $82.3 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 billion, up 38.53% from the prior year.
Assets Average held at $82.3 million in Q4 2016.
In the past five years, Assets Average ranged from a high of $82.3 million in Q4 2016 to a low of $82.3 million in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	26.95 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	41.30 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	3.29 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.86 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	16.08 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	19.82 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	5.34 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	2.09 Bn
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	5.51 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2016	82.29 Mn